Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 10
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
Alessandro Rodolico, Pierfelice Cutrufelli, Antonio Di Francesco, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 8
Effects of epidural esketamine versus sufentanil on labor analgesia and postpartum depression: a retrospective cohort study
Kunyue Li, Ziqi Chai, Chunyun Deng, et al.
BMC Anesthesiology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation
Jiachi Xu, M Li, Yu Hu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study
Paul Glue, Shona Neehoff, Ben Beaglehole, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 2, pp. 162-167
Open Access | Times Cited: 7
Ketamine’s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine’s antidepressant effects?
Brandi Quintanilla, Carlos A. Zarate, Anilkumar Pillai
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2849-2858
Closed Access | Times Cited: 7
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6
Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells
Ming Li, Xueke Yang, Jian Yang, et al.
Neuron (2024) Vol. 112, Iss. 18, pp. 3192-3210.e6
Closed Access | Times Cited: 5
Exploring the impact of music on response to ketamine/esketamine: A scoping review
Mina Kheirkhah, Allison C. Nugent, Alicia A. Livinski, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105693-105693
Closed Access | Times Cited: 4
Esketamine in depression: putative biomarkers from clinical research
Jenessa N. Johnston, Carlos A. Zarate, Mark D. Kvarta
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Intravenous esketamine in pediatric Rett syndrome: An open-label, early phase 1 pilot study
Huiping Li, Shuming Liu, Caimei Lin, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101413-101413
Open Access
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Protective Effects of Trolox on Ketamine-Induced Memory Impairments and Morphological Changes in the Brain
Emre Uyar, Meral Erdinç, İlker Kelle, et al.
International Journal of Pharmacology (2025) Vol. 21, Iss. 1, pp. 27-36
Closed Access
The role of esketamine in persistent long COVID with predominant psychiatric manifestations
Ina Bozic, Dominik Ivkic, Lutz Reinfried, et al.
European Neuropsychopharmacology (2025) Vol. 93, pp. 66-67
Closed Access
Assessment of complement cascade components in patients with major depressive disorder
Brandi Quintanilla, Dede Greenstein, Ashutosh Tripathi, et al.
Brain Behavior and Immunity (2025)
Closed Access
Mechanisms of SSRI Therapy and Discontinuation
Trevor Sharp, Helen Collins
Current topics in behavioral neurosciences (2023), pp. 21-47
Closed Access | Times Cited: 11
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone’
M. Pappagallo, Thomas R. Kosten, Charles W. Gorodetzky, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3935-3937
Open Access | Times Cited: 3
Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice
Ziteng Zheng, Han Zhou, Lu Yang, et al.
Behavioural Brain Research (2024) Vol. 463, pp. 114888-114888
Open Access | Times Cited: 2
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity
Stefano Comai, Sara De Martin, Andrea Mattarei, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1618-1618
Open Access | Times Cited: 2
Ketamine Infusion in a Resistant Obsessive-Compulsive Disorder Patient in Bangladesh with Severe Suicidal Ideation: A Case Report
Sultana Algin, Debasish Banik, SM Atikur Rahman, et al.
Cureus (2024)
Open Access | Times Cited: 1
Intravenous infusion with esketamine rapidly alleviates refractory somatic symptom disorder: A case report
Shikai Wang, Yong Xu, Xiaoqing Xiao, et al.
Asian Journal of Psychiatry (2024) Vol. 97, pp. 104076-104076
Closed Access | Times Cited: 1
Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation.
Milan Van Maldegem, Jakub Vohryzek, Selen Atasoy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top